Compare Definium Therapeutics Inc. Common Shares (DFTX) vs GameStop Corp. (GME) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs GameStop Corp. — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while GameStop Corp. trades at $25.31 (market cap $12.40B). The key difference: GameStop Corp. is far larger — about 2.6× Definium Therapeutics Inc. Common Shares's market cap, and GameStop Corp. is trading nearer its 52-week high, Definium Therapeutics Inc. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and GameStop Corp. for 61 Days on average.
| DFTX | GME | |
|---|---|---|
Market Cap | $4.71B | $12.40B |
Volume | 1,966,636 | 7,567,400 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.45 | $26.53 |
52-Week Low | $10.68 | $17.87 |
Typical Hold Time | 0 Days | 61 Days |
Enterprise Value | $3.67B | $11.67B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GME trades at $25.28, up 2.1% on the day, with a bullish technical signal from moving averages. The company reported a net income of $131.3 million in 2025, a significant improvement from prior losses, and holds a strong cash position of $4.77 billion. Recent insider buying by CEO Ryan Cohen, including a $26.4 million purchase disclosed on September 21, 2026 (The Motley Fool), has fueled positive sentiment.
The outlook is mixed; strong cash reserves and insider confidence support upside, but declining revenue from $5.3B in 2024 to $3.8B in 2025 poses a growth risk. Analyst consensus is cautious with only 16.7% buy ratings. Key risks include execution challenges in the retail sector and high volatility typical of meme stocks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About GameStop Corp.
Global Market Group Ltd. operates an Internet website that connects Chinese manufacturers with international buyers. The Company's customers can post company profiles and product information in standardized formats; post product listings; and trade leads.
Read more on GME →
